Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsAt CHEST 2026, Pourshahid argued for matching patients to center-based, hybrid, or virtual pulmonary rehab based on a structured assessment.
Omid Pourshahid, MD, MPH, discusses Medicare coverage for virtual pulmonary rehab and a matched-care pathway for center-based, hybrid, or virtual programs.
Experts Examine Biologic Coverage in Asthma and COPD
Type 2 Phenotyping in Asthma and COPD: Clinical Forum Perspectives
Ralinepag Cuts PAH Worsening in Low-Risk Patients, With Jean Elwing, MD
Data from the real-world, CONFIDENCE study found switching from intravenous to subcutaneous ocrelizumab was well tolerated in patients with relapsing and primary progressive MS.
The phase 2 FENerations1 study is an open-label, single-arm, small-scale study evaluating fenebrutinib dosing in 8 to 12 children and adolescents with relapsing MS.
1.
J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79
2.
Three out of ten breast cancers detected between screenings, study finds
3.
MRD Tied to PFS in Lymphoma Patients on Epcoritamab
4.
AI can identify women at risk of breast cancer years in advance: Study
5.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
1.
Interpreting Iron Studies: What Your Blood Results Really Mean
2.
The Mysterious Pain of Scrotal Hematoma: A Guide to Diagnosis and Treatment
3.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
4.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
5.
Preventing Treatment-Related Secondary Malignancies: Evidence-Based Strategies for Clinical Practice
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Navigating the Complexities of Ph Negative ALL - Part IV
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
4.
Signs and Symptoms of Leukemia
5.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge